moxifloxacin has been researched along with Hyperemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitterman, A; Chruscicki, DA; Cohn, S; Donnenfeld, E; Perry, HD; Solomon, R | 1 |
| Cetinkaya, Z; Ermis, SS; Inan, UU; Kiyici, H; Ozturk, F | 1 |
1 trial(s) available for moxifloxacin and Hyperemia
| Article | Year |
|---|---|
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
Topics: Adult; Anterior Chamber; Aza Compounds; Conjunctiva; Eye; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperemia; Irritants; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pain; Pupil; Quinolines | 2004 |
1 other study(ies) available for moxifloxacin and Hyperemia
| Article | Year |
|---|---|
Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Aza Compounds; Colony Count, Microbial; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edema; Endophthalmitis; Fluoroquinolones; Hyperemia; Injections; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitreous Body | 2007 |